Oil surge lifts shares: Social media discussions highlight BP's strong year-to-date performance, with shares up over 35% amid escalating Middle East tensions driving crude prices higher. Investors point to technical breakouts from long-term downtrends and attractive dividend yields around 4.4% as key draws. The rally follows refinery disruptions and threats in key shipping lanes like the Strait of Hormuz.
Geopolitical tailwinds: Traders on social media note pre-war purchases yielding 45% gains, underscoring the stock's sensitivity to oil volatility. Optimism centers on sustained higher crude amid resilient demand and supply constraints from offshore cuts. Some highlight political interest, including recent congressional disclosures of BP holdings.
Mixed fuel price chatter: While stock enthusiasts celebrate, UK users debate retail fuel margins amid wartime spikes. Executive shifts at BP Ventures draw attention, signaling pivots in venture focus away from EVs. Overall, the conversation underscores energy sector resilience.
Note: This discussion summary was generated from an AI condensation of post data.
BP Congressional Stock Trading
Members of Congress have traded $BP stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BP stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 2 purchases worth up to $65,000 on 03/20, 03/19 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BP Hedge Fund Activity
We have seen 483 institutional investors add shares of BP stock to their portfolio, and 459 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAXTON ASSOCIATES LLP added 10,409,750 shares (+inf%) to their portfolio in Q4 2025, for an estimated $361,530,617
- ACADIAN ASSET MANAGEMENT LLC added 6,166,075 shares (+146.4%) to their portfolio in Q4 2025, for an estimated $214,147,784
- BNP PARIBAS FINANCIAL MARKETS removed 4,811,290 shares (-59.5%) from their portfolio in Q4 2025, for an estimated $167,096,101
- CITADEL ADVISORS LLC removed 4,444,917 shares (-63.4%) from their portfolio in Q4 2025, for an estimated $154,371,967
- NORGES BANK removed 3,244,022 shares (-34.4%) from their portfolio in Q4 2025, for an estimated $112,664,884
- POINT72 ASSET MANAGEMENT, L.P. removed 3,203,609 shares (-67.7%) from their portfolio in Q4 2025, for an estimated $111,261,340
- MEREWETHER INVESTMENT MANAGEMENT, LP added 3,008,100 shares (+inf%) to their portfolio in Q4 2025, for an estimated $104,471,312
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BP Analyst Ratings
Wall Street analysts have issued reports on $BP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 10/17/2025
To track analyst ratings and price targets for BP, check out Quiver Quantitative's $BP forecast page.
BP Price Targets
Multiple analysts have issued price targets for $BP recently. We have seen 5 analysts offer price targets for $BP in the last 6 months, with a median target of $39.0.
Here are some recent targets:
- Kim Fustier from HSBC set a target price of $45.3 on 03/20/2026
- Ryan Todd from Piper Sandler set a target price of $47.0 on 03/12/2026
- Stephen Richardson from Evercore ISI Group set a target price of $38.0 on 01/06/2026
- Sam Margolin from Wells Fargo set a target price of $39.0 on 11/05/2025
- Justin Jenkins from Raymond James set a target price of $38.0 on 10/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.